ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.67
0.54%
US Tech 100
18,329.60
1.01%
S&P 500
5,305.09
0.71%
US Dollar vs CAD
1.36562
-0.56%
Bitcoin
68,876.41
1.41%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Exagen Inc (XGN)

  7. Exagen Inc (XGN) News

XGN

Exagen (XGN)

Exagen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XGN
DateTimeSourceHeadlineSymbolCompany
05/16/20247:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
05/14/20243:25PMAllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
05/13/20248:30AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
05/13/20248:27AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
05/13/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
05/13/20247:00AMGlobeNewswire Inc.Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearNASDAQ:XGNExagen Inc
05/06/20243:05PMGlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
04/30/20243:05PMGlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
04/26/20247:30AMGlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
03/18/20247:00AMGlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
03/18/20246:12AMIH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
03/08/20248:00AMGlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
03/07/20243:05PMGlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
03/06/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
03/04/20243:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
02/22/20243:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
02/22/20243:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
02/14/20246:12AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
02/13/20243:35PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
02/08/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
02/02/20242:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
01/30/20243:05PMGlobeNewswire Inc.Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:XGNExagen Inc
01/22/20243:15PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
01/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
01/07/202411:00AMGlobeNewswire Inc.Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceNASDAQ:XGNExagen Inc
12/11/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
11/29/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XGNExagen Inc
11/29/20234:11PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
11/27/20233:05PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:XGNExagen Inc
11/20/20237:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN

Your Recent History

LSE
WIL
Wilmington
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved